July 29, 2017Open Access
View Full PaperBiofluid biomarkers of traumatic brain injury
Key Points
Key points are not available for this paper at this time.
Abstract
The identification of biofluid biomarkers could play a vital role in identifying, diagnosing, and treating the underlying individual pathobiological changes of TBI. CNS-derived exosomes analyzed by ultra-high sensitivity detection methods have the potential to identify blood biomarkers for the range of TBI severity and time course.